Dec 3, 1977

Treatment of acute viral hepatitis with (+)-cyanidanol-3

Lancet
A L BlumN Tygstrup

Abstract

A double-blind trial of (+)-cyanidanol-3 (2 g/day) versus placebo tablets was carried out in 100 patients with acute viral hepatitis. 51 received the drug and 49 placebo. (+)-Cyanidanol-3 accelerated the disappearance of HBsAg from the blood, lowered serum-bilirubin, and relieved symptoms such as anorexia, nausea, and pruritus. The drug was well tolerated. None of the patients had a relapse of acute hepatitis. Chronic active hepatitis developed in 1 of the placebo-treated patients. Thus, (+)-cyanidanol-3 seems to be of benefit in acute viral hepatitis.

  • References3
  • Citations26
  • References3
  • Citations26

Citations

Mentioned in this Paper

Benzopyrans
Anorexia
Hepatitis B Antigens
Bilirubin
Bilirubin, (4E,15E)-Isomer
Serum Bilirubin Measurement
Alkaline Phosphatase
Blood Bilirubin Measurement
Hepatitis B antigen peptide
Cyanidanol-3

About this Paper

Related Feeds

Anorexia Nervosa

Anorexia nervosa (AN) is a psychiatric condition characterized by severe weight loss and secondary problems associated with malnutrition. Here is the latest research on AN.